184 related articles for article (PubMed ID: 28463792)
1. Co-delivery of vincristine and quercetin by nanocarriers for lymphoma combination chemotherapy.
Zhu B; Yu L; Yue Q
Biomed Pharmacother; 2017 Jul; 91():287-294. PubMed ID: 28463792
[TBL] [Abstract][Full Text] [Related]
2. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
[TBL] [Abstract][Full Text] [Related]
3. Lymphoma-targeted treatment using a folic acid-decorated vincristine-loaded drug delivery system.
Qiu L; Dong C; Kan X
Drug Des Devel Ther; 2018; 12():863-872. PubMed ID: 29713144
[TBL] [Abstract][Full Text] [Related]
4. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
Li C; Ge X; Wang L
Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
[TBL] [Abstract][Full Text] [Related]
5. Lymph cancer chemotherapy: delivery of doxorubicin-gemcitabine prodrug and vincristine by nanostructured lipid carriers.
Ni S; Qiu L; Zhang G; Zhou H; Han Y
Int J Nanomedicine; 2017; 12():1565-1576. PubMed ID: 28280326
[TBL] [Abstract][Full Text] [Related]
6. RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.
Wang G; Wang Z; Li C; Duan G; Wang K; Li Q; Tao T
Biomed Pharmacother; 2018 Oct; 106():275-284. PubMed ID: 29966971
[TBL] [Abstract][Full Text] [Related]
7. Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid-polymer hybrid nanoparticles.
Liu J; Cheng H; Han L; Qiang Z; Zhang X; Gao W; Zhao K; Song Y
Drug Des Devel Ther; 2018; 12():3199-3209. PubMed ID: 30288024
[TBL] [Abstract][Full Text] [Related]
8. The effective combination therapy against human osteosarcoma: doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system.
Wang L; Wang W; Rui Z; Zhou D
Drug Deliv; 2016 Nov; 23(9):3200-3208. PubMed ID: 26987435
[TBL] [Abstract][Full Text] [Related]
9. TAT modified and lipid - PEI hybrid nanoparticles for co-delivery of docetaxel and pDNA.
Dong S; Zhou X; Yang J
Biomed Pharmacother; 2016 Dec; 84():954-961. PubMed ID: 27764758
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous liposomal delivery of quercetin and vincristine for enhanced estrogen-receptor-negative breast cancer treatment.
Wong MY; Chiu GN
Anticancer Drugs; 2010 Apr; 21(4):401-10. PubMed ID: 20110806
[TBL] [Abstract][Full Text] [Related]
11. Liposome formulation of co-encapsulated vincristine and quercetin enhanced antitumor activity in a trastuzumab-insensitive breast tumor xenograft model.
Wong MY; Chiu GN
Nanomedicine; 2011 Dec; 7(6):834-40. PubMed ID: 21371568
[TBL] [Abstract][Full Text] [Related]
12. Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy.
Zhang J; Xiao X; Zhu J; Gao Z; Lai X; Zhu X; Mao G
Int J Nanomedicine; 2018; 13():3039-3051. PubMed ID: 29861635
[TBL] [Abstract][Full Text] [Related]
13. Transcription activator, hyaluronic acid and tocopheryl succinate multi-functionalized novel lipid carriers encapsulating etoposide for lymphoma therapy.
Wang H; Sun G; Zhang Z; Ou Y
Biomed Pharmacother; 2017 Jul; 91():241-250. PubMed ID: 28460227
[TBL] [Abstract][Full Text] [Related]
14. Novel transferrin modified and doxorubicin loaded Pluronic 85/lipid-polymeric nanoparticles for the treatment of leukemia: In vitro and in vivo therapeutic effect evaluation.
Zhu B; Zhang H; Yu L
Biomed Pharmacother; 2017 Feb; 86():547-554. PubMed ID: 28024291
[TBL] [Abstract][Full Text] [Related]
15. Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction.
Zhang S; Li J; Hu S; Wu F; Zhang X
Int J Nanomedicine; 2018; 13():4045-4057. PubMed ID: 30022826
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of doxorubicin and vincristine to lymph cancer: evaluation of novel nanostructured lipid carriers in vitro and in vivo.
Dong X; Wang W; Qu H; Han D; Zheng J; Sun G
Drug Deliv; 2016 May; 23(4):1374-8. PubMed ID: 26208133
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration.
Thanki K; van Eetvelde D; Geyer A; Fraire J; Hendrix R; Van Eygen H; Putteman E; Sami H; de Souza Carvalho-Wodarz C; Franzyk H; Nielsen HM; Braeckmans K; Lehr CM; Ogris M; Foged C
J Control Release; 2019 Sep; 310():82-93. PubMed ID: 31398360
[TBL] [Abstract][Full Text] [Related]
18. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H
Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
[TBL] [Abstract][Full Text] [Related]
19. α
Qiu J; Cai G; Liu X; Ma D
Biomed Pharmacother; 2017 Dec; 96():1418-1426. PubMed ID: 29079344
[TBL] [Abstract][Full Text] [Related]
20. Lipid-based nanocarrier for quercetin delivery: system characterization and molecular interactions studies.
Hädrich G; Monteiro SO; Rodrigues MR; de Lima VR; Putaux JL; Bidone J; Teixeira HF; Muccillo-Baisch AL; Dora CL
Drug Dev Ind Pharm; 2016; 42(7):1165-73. PubMed ID: 26571009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]